Stay updated on Topical BMX-010 in Skin Diseases Clinical Trial
Sign up to get notified when there's something new on the Topical BMX-010 in Skin Diseases Clinical Trial page.

Latest updates to the Topical BMX-010 in Skin Diseases Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.3.2 was added and v3.2.0 was removed in the page revision history, with no substantive changes to the study details, eligibility criteria, outcomes, or locations.SummaryDifference0.1%

- Check20 days agoChange DetectedThe notice about a lapse in government funding and potential delays in updates has been removed from the page.SummaryDifference0.4%

- Check34 days agoChange DetectedNo significant changes detected in core study content, only formatting/UI updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check63 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference5%

- Check70 days agoChange DetectedPage now shows Revision: v3.1.0 and removes several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) from the content; core page content appears to be re-scoped rather than expanded.SummaryDifference0.6%

- Check84 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; Back to Top was removed.SummaryDifference0.3%

Stay in the know with updates to Topical BMX-010 in Skin Diseases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Topical BMX-010 in Skin Diseases Clinical Trial page.